DHR vs WFC: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and Wells Fargo & Company — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-23.
Danaher Corporation · Healthcare
$221.12
+29.6% upside to fair value
Med Conviction
Grade B
High Quality
VS
Wells Fargo & Company · Financial Services
$86.12
+20.4% upside to fair value
Med Conviction
Grade B
QuantHub Verdict
DHR has more upside to fair value
(+29.6%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
WFC |
| Current Price |
$221.12 |
$86.12 |
| Fair Value Estimate |
$286.52 |
$103.68 |
| Upside to Fair Value |
+29.6%
|
+20.4%
|
| Market Cap |
$155.4B |
$260.4B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
24.8x
|
15.6x
|
| Price / Sales |
6.2x
|
2.0x
|
| Price / FCF |
28.5x
|
13.7x
|
| Revenue Growth YoY |
+5.5%
|
+11.3%
|
| Gross Margin |
58.5%
|
64.5%
|
| Operating Margin |
20.4%
|
21.2%
|
| Return on Equity |
7.7%
|
12.6%
|
| Dividend Yield |
0.65% |
2.15% |
| FCF Yield |
3.51%
|
7.3%
|
| Analyst Consensus |
Strong Buy
|
Hold
|
Investment Thesis
Danaher is a diversified life-sciences and diagnostics platform spanning three segments: Life Sciences (mass spectrometers, flow cytometry, genomics, bioprocess technologies), Diagnostics (chemistry, immunoassay, microbiology, hematology, molecular and pathology systems), and Environmental & Applied Solutions (water quality and product-identification instrumentation). The business quality is high…
Wells Fargo is a diversified U.S. bank with roughly 197,000 employees operating four segments: Consumer Banking and Lending, Commercial Banking, Corporate and Investment Banking, and Wealth and Investment Management. The business quality is solid but not exceptional: trailing return on equity is 12.6%, TTM net margin is 17.5%, and revenue grew 11.3% year over year in the most recent quarter while…
Accumulation Zones
| Metric |
DHR |
WFC |
| Zone Low |
$214.89 |
$77.76 |
| Zone High |
$243.54 |
$88.13 |
| In Buy Zone? |
Yes
|
Yes
|